Immune checkpoint inhibitors and diabetes mellitus

Gao Ya; Li Naishi; Zhao Weigang

doi:10.13406/j.cnki.cyxb.002788

您当前的位置：

首页 >

文章列表页 >

Immune checkpoint inhibitors and diabetes mellitus

更新时间：2024-01-09

- Immune checkpoint inhibitors and diabetes mellitus
- Journal of Chongqing Medical University Vol. 46, Issue 5, Pages: 598-609(2021)
- 作者机构：
  
  中国医学科学院北京协和医学院北京协和医院内分泌科、国家卫生健康委员会内分泌重点实验室,北京,100730
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.002788
  CLC： R587.1
- Published：2021，
扫描看全文
Gao Ya, Li Naishi, Zhao Weigang. Immune checkpoint inhibitors and diabetes mellitus. [J]. Journal of Chongqing Medical University 46(5):598-609(2021)
DOI：

Gao Ya, Li Naishi, Zhao Weigang. Immune checkpoint inhibitors and diabetes mellitus. [J]. Journal of Chongqing Medical University 46(5):598-609(2021) DOI： 10.13406/j.cnki.cyxb.002788.

摘要

免疫检查点抑制剂治疗所引发的糖尿病是其引起的相关内分泌系统不良反应中较为少见的一种类型。但该类型糖尿病常常以糖尿病酮症酸中毒起病，较为凶险。本文对免疫检查点抑制剂引起糖尿病的文献进行了系统回顾，并对其临床表现和诊疗对策作一综述。

Abstract

Diabetes mellitus caused by immune checkpoint inhibitors is a rare type of immune-related adverse events in endocrinology. However

this type of diabetes often begins with diabetic ketoacidosis

which is more dangerous. This article reviews the literatures on immune checkpoint inhibitors-induced diabetes mellitus and its clinical manifestations and diagnosis and treatment strategies.

关键词

免疫检查点抑制剂糖尿病免疫相关不良反应免疫治疗

Keywords

immune checkpoint inhibitorsdiabetes mellitusimmune-related adverse eventsimmunotherapy

references

查看原文

Views

251

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Interpretation of French Endocrine Society Guidance on endocrine side effects of immunotherapy

Advances in immunotherapy in EGFR-mutated non-small cell lung cancer

Predictive value of NLR and PLR for outcome after immunotherapy in advanced urothelial carcinoma

Immunotherapy: a promising therapy for anaplastic thyroid carcinoma

Protection of sodium glucose cotransporter-2 inhibitors on diabetic nephropathy

Related Author

Wu Qinan

Wei Kunchen

Wu Junfeng

Tang Hao

Chen Yingye

Chen Yong

Jiang Qing

Wei Xiaohang

Related Institution

Endocrinology and Nephrology Department，Chongqing University Cancer Hospital

Beijing Garrison District Haidian 40th Separation Cadre Retreat

Department of Respiratory and Critical Care Medicine,Shanghai Changzheng Hospital

Department of Urology,The Second Affiliated Hospital of Chongqing Medical University

Department of Urology,Chongqing University Fuling Hospital

⁰